EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PAX8 ‐positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles – A clinicopathologic study of 101 consecutive cases with next‐generation sequencing in 20 cases

Sarah Mae Lammert iD, Wendy Luo iD, Allen C Zhu iD, Peng Wang iD, Tatjana Antic iD, Jung Woo Kwon iD

Histopathology · 2026

DOI: 10.1111/his.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Sarah Mae Lammert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: PAX8 Transcription Factor, Urinary Bladder Neoplasms, Biomarkers, Tumor, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

PAX8 immunohistochemistry (IHC) is often used to distinguish urothelial carcinomas (UCs) from tumours of renal and Mullerian origin. However, some UCs have been shown to be PAX8‐positive. This study investigates the frequency of PAX8‐positive conventional UCs of the urinary bladder without subtype morphology and/or divergent differentiation and their molecular profiles.

Methods

One hundred and one consecutive transurethral resections of the urinary bladder from 2019 to 2022 with a diagnosis of conventional urothelial carcinoma (UC) without subtype morphology and/or divergent differentiation were retrospectively reviewed. Representative sections were selected for whole‐slide PAX8 IHC (10336‐1‐AP; polyclonal). Next‐generation sequencing (NGS) was performed on all PAX8‐positive cases and on a subset of PAX8‐negative cases.

Results

PAX8 IHC was positive in 10% (10/101) of cases. Twenty cases underwent NGS, including all 10 PAX8‐positive UCs. All PAX8‐positive UCs had TERT promoter mutations. TSC1 alterations, NOTCH1 loss and WT1 loss were more frequent in the PAX8‐positive cases compared with the PAX8‐negative cases. RB1 loss was not seen in the PAX8‐positive UCs, while it was present in 40% of the PAX8‐negative UCs.

Conclusions

A subset of conventional UCs of the urinary bladder without subtype morphology and/or divergent differentiation are PAX8‐positive and have frequent alterations in TERT promoter, TSC1 , NOTCH1 , and WT1 , with an absence of RB1 loss. PAX8 positivity should be interpreted with caution if UC is in the differential, and NGS could be helpful in diagnostic workups as this study shows PAX8‐positive UCs may have a distinct molecular profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PAX8 Transcription FactorUrinary Bladder NeoplasmsBiomarkers, TumorCarcinoma, Transitional CellHumansFemaleHigh-Throughput Nucleotide SequencingMaleAgedTuberous Sclerosis Complex 1 ProteinTelomeraseRetrospective StudiesMiddle AgedImmunohistochemistryAged, 80 and overReceptor, Notch1MutationWT1 ProteinsPromoter Regions, GeneticAdult

Stichwörter der Autor:innen

TSC1PAX8TERT promoterbladderurothelial carcinoma

Substanzen

PAX8 Transcription FactorPAX8 protein, humanBiomarkers, TumorTuberous Sclerosis Complex 1 ProteinTelomeraseTSC1 protein, humanTERT protein, humanReceptor, Notch1NOTCH1 protein, humanWT1 Proteins

Autor:innen und Institutionen

  • Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
  • Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Sarah Mae Lammert, Wendy Luo, Allen C Zhu, Peng Wang, Tatjana Antic, Jung Woo Kwon

Zitieren

APA

Lammert, S. M., Luo, W., Zhu, A. C., Wang, P., Antic, T., & Kwon, J. W. (2026). PAX8 ‐positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles – A clinicopathologic study of 101 consecutive cases with next‐generation sequencing in 20 cases. Histopathology. https://doi.org/10.1111/his.70112

Vancouver

Lammert SM, Luo W, Zhu AC, Wang P, Antic T, Kwon JW. PAX8 ‐positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles – A clinicopathologic study of 101 consecutive cases with next‐generation sequencing in 20 cases. Histopathology. 2026. doi:10.1111/his.70112

BibTeX
@article{Lammert2026,
  author = {Lammert, Sarah Mae and Luo, Wendy and Zhu, Allen C and Wang, Peng and Antic, Tatjana and Kwon, Jung Woo},
  title = {PAX8 ‐positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles – A clinicopathologic study of 101 consecutive cases with next‐generation sequencing in 20 cases},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70112}
}
Kostenlos starten →